Study of Low-level Laser Therapy in the Acute Treatment of Migraine
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: The San Francisco Clinical Research Center
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
This study evaluates the treatment of migraine pain using low energy laser light to quench migraine signals issuing from the sphenopalatine ganglion (SPG).
Research Team
Eligibility Criteria
Inclusion Criteria
aged 18 or older;
subject diagnosed with migraine according to The International Classification of Headache Disorders- Version 3;
1-20 headache days per month;
See 2 more
Treatment Details
Interventions
- Argus Migraine Treatment device (Device)
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: TreatmentActive Control1 Intervention
Treatment laser.
Group II: ShamPlacebo Group1 Intervention
Sham low energy laser using approximately 1/1000 th energy of treatment laser.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
San Francisco Clinical Research CenterSan Francisco, CA
Loading ...
Who Is Running the Clinical Trial?
The San Francisco Clinical Research Center
Lead Sponsor
Trials
1
Patients Recruited
60+